CoChat

Dual regulatory switch through interactions of Tcf7l2/Tcf4 with stage-specific partners propels oligodendroglial maturation

Open access

The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.

Abstract

Constitutive activation of Wnt/β-catenin inhibits oligodendrocyte myelination. Tcf7l2/Tcf4, a β-catenin transcriptional partner, is required for oligodendrocyte differentiation. How Tcf7l2 modifies β-catenin signalling and controls myelination remains elusive. Here we define a stage-specific Tcf7l2-regulated transcriptional circuitry in initiating and sustaining oligodendrocyte differentiation. Multistage genome occupancy analyses reveal that Tcf7l2 serially cooperates with distinct co-regulators to control oligodendrocyte lineage progression. At the differentiation onset, Tcf7l2 interacts with a transcriptional co-repressor Kaiso/Zbtb33 to block β-catenin signalling. During oligodendrocyte maturation, Tcf7l2 recruits and cooperates with Sox10 to promote myelination. In that context, Tcf7l2 directly activates cholesterol biosynthesis genes and cholesterol supplementation partially rescues oligodendrocyte differentiation defects in Tcf712 mutants. Together, we identify stage-specific co-regulators Kaiso and Sox10 that sequentially interact with Tcf7l2 to coordinate the switch at the transitions of differentiation initiation and maturation during oligodendrocyte development, and point to a previously unrecognized role of Tcf7l2 in control of cholesterol biosynthesis for CNS myelinogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/ncomms10883

Cites

66 of 66 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 OL differentiation defects in the brain of Tcf7l2ΔHMG mice lacking the DNA-binding HMG domain. (a) Schematic diagram shows domains in Tcf7l2 (upper) and Cre-mediated excision (lower) of the floxed exon 11, which encodes the DNA-binding HMG domain. NLS: Nuclear localization sequence. (b) Upper panel, expression of Tcf7l2 exon 11 in the mRNAs of OPCs isolated from control (Ctrl) and Tcf7l2ΔHMG brains at P2 was assayed by qRT–PCR (n=3 animals per genotype). Lower panel: western blot analysis of the spinal cords from control and Tcf7l2ΔHMG mice at P10 with anti-Tcf7l2 (amino-terminal epitope) and glyceraldehydes 3-phosphate dehydrogenase (GAPDH; loading control). (c) Expression of Mbp and Plp1 in cortices from control and Tcf7l2ΔHMG mice by in situ hybridization. Arrows indicate the cerebral white matter in coronal sections, except P60 Mbp in sagittal sections. (d) MBP immunostaining in the cortices from control and Tcf7l2ΔHMG mice at P14 assayed by immunohistochemistry. (e) Expression of membrane-anchored enhanced GFP (EGFP) driven by a CNP promoter in the cortices from control and Tcf7l2ΔHMG mice carrying the CNP-mGFP transgene at P14. (f) Quantification of Plp1+ OLs (per mm2) in the cortex of control and Tcf7l2ΔHMG at P60; n=3 animals per genotype. (g) The cortices of Ctrl and Tcf7l2ΔHMG mice at P14 were immunostained with anti-PDGFRα antibody. (h) PDGFRα+ OPC numbers were quantified per mm2; n=3 animals per genotype. (i) BrdU incorporation in the cortex of control and Tcf7l2ΔHMG mice carrying PDGFRα-GFP reporter and pulse labelled with BrdU for 2 h at P14. (j) BrdU+/PDGFRα+ OPC cell numbers were quantified per mm2; n=3 animals per genotype. (k,l) Electron microscopy of the optic nerves (OP) and corpus callosum (CC) of control and Tcf7l2ΔHMG mice at P14 and P60. (m) The percentages of myelinated axons in the OP and CC at P14 and P60; n=3 animals per genotype. Data are presented as mean±s.e.m. ***P<0.001; Student's t-test. Scale bars, 100 μm (c,d), 50 μm (e,g–j) and 2 μm (k,l).
Figure 1 OL differentiation defects in the brain of Tcf7l2ΔHMG mice lacking the DNA-binding HMG domain. (a) Schematic diagram shows domains in Tcf7l2 (upper) and Cre-mediated excision (lower) of the floxed exon 11, which encodes the DNA-binding HMG domain. NLS: Nuclear localization sequence. (b) Upper panel, expression of Tcf7l2 exon 11 in the mRNAs of OPCs isolated from control (Ctrl) and Tcf7l2ΔHMG brains at P2 was assayed by qRT–PCR (n=3 animals per genotype). Lower panel: western blot analysis of the spinal cords from control and Tcf7l2ΔHMG mice at P10 with anti-Tcf7l2 (amino-terminal epitope) and glyceraldehydes 3-phosphate dehydrogenase (GAPDH; loading control). (c) Expression of Mbp and Plp1 in cortices from control and Tcf7l2ΔHMG mice by in situ hybridization. Arrows indicate the cerebral white matter in coronal sections, except P60 Mbp in sagittal sections. (d) MBP immunostaining in the cortices from control and Tcf7l2ΔHMG mice at P14 assayed by immunohistochemistry. (e) Expression of membrane-anchored enhanced GFP (EGFP) driven by a CNP promoter in the cortices from control and Tcf7l2ΔHMG mice carrying the CNP-mGFP transgene at P14. (f) Quantification of Plp1+ OLs (per mm2) in the cortex of control and Tcf7l2ΔHMG at P60; n=3 animals per genotype. (g) The cortices of Ctrl and Tcf7l2ΔHMG mice at P14 were immunostained with anti-PDGFRα antibody. (h) PDGFRα+ OPC numbers were quantified per mm2; n=3 animals per genotype. (i) BrdU incorporation in the cortex of control and Tcf7l2ΔHMG mice carrying PDGFRα-GFP reporter and pulse labelled with BrdU for 2 h at P14. (j) BrdU+/PDGFRα+ OPC cell numbers were quantified per mm2; n=3 animals per genotype. (k,l) Electron microscopy of the optic nerves (OP) and corpus callosum (CC) of control and Tcf7l2ΔHMG mice at P14 and P60. (m) The percentages of myelinated axons in the OP and CC at P14 and P60; n=3 animals per genotype. Data are presented as mean±s.e.m. ***P<0.001; Student's t-test. Scale bars, 100 μm (c,d), 50 μm (e,g–j) and 2 μm (k,l).CC BY · PubMed Central
Figure 2 Tcf7l2 ablation impairs remyelination in LPC-induced demyelinating animal model. (a,b) Expression of Mbp in the spinal cord from control (Ctrl) and Tcf7l2ΔHMG mice at indicated neonatal and adult ages by in situ hybridization. (c) Electron microscopy of the spinal white matter of control and Tcf7l2ΔHMG mice at P60. The percentages of myelinated axons (d) and g-ratio (e) in the spinal white matter of control and Tcf7l2ΔHMG mice at P60. The data represent the means±s.e.m.; n=3 animals per genotype. (f) Left: the location of LPC-induced lesion (DAPI counterstaining, dashed lines) in the spinal cord. Right: in situ hybridization analysis showed re-expression of Tcf7l2 in the LPC-induced demyelinating lesions (demarcated with dashed lines) and uninjured regions at 7 and 14 dpl in spinal cords of P60 mice. (g) In situ hybridization analysis of PDGFRα, Mbp and Plp1 in the lesion regions (demarcated with dashed lines) at 14 dpl in spinal cords of P60 Ctrl and Tcf7l2ΔHMG mutant mice. Quantification of the numbers of PDGFRα+ OPC (h) and Plp1+ OL (i) at 14 dpl in spinal cords of P60 control and Tcf7l2ΔHMG mutant mice; n=5 animals for each genotype. (j) Representative electron micrographs of spinal cords of 8-week-old control and Tcf7l2ΔHMG mice at 14 dpl. Arrow indicates the newly formed thin myelin sheath. (k) Quantification of the percentage newly myelinated axons in spinal lesions of 8-week-old control and Tcf7l2ΔHMG mice at 14 dpl; n=3 animals for each genotype. (l) Quantification of g-ratio of newly myelinated axons in spinal lesions of 8-week-old control and Tcf7l2ΔHMG mice at 14 dpl; n=3 animals for each genotype. P<0.001, Student's t-test. Data are presented as mean±s.e.m. **P<0.01, ***P<0.001; Student's t-test. Scale bars, 100 μm (a,b), 2 μm (c,j) and 50 μm (f,g).
Figure 2 Tcf7l2 ablation impairs remyelination in LPC-induced demyelinating animal model. (a,b) Expression of Mbp in the spinal cord from control (Ctrl) and Tcf7l2ΔHMG mice at indicated neonatal and adult ages by in situ hybridization. (c) Electron microscopy of the spinal white matter of control and Tcf7l2ΔHMG mice at P60. The percentages of myelinated axons (d) and g-ratio (e) in the spinal white matter of control and Tcf7l2ΔHMG mice at P60. The data represent the means±s.e.m.; n=3 animals per genotype. (f) Left: the location of LPC-induced lesion (DAPI counterstaining, dashed lines) in the spinal cord. Right: in situ hybridization analysis showed re-expression of Tcf7l2 in the LPC-induced demyelinating lesions (demarcated with dashed lines) and uninjured regions at 7 and 14 dpl in spinal cords of P60 mice. (g) In situ hybridization analysis of PDGFRα, Mbp and Plp1 in the lesion regions (demarcated with dashed lines) at 14 dpl in spinal cords of P60 Ctrl and Tcf7l2ΔHMG mutant mice. Quantification of the numbers of PDGFRα+ OPC (h) and Plp1+ OL (i) at 14 dpl in spinal cords of P60 control and Tcf7l2ΔHMG mutant mice; n=5 animals for each genotype. (j) Representative electron micrographs of spinal cords of 8-week-old control and Tcf7l2ΔHMG mice at 14 dpl. Arrow indicates the newly formed thin myelin sheath. (k) Quantification of the percentage newly myelinated axons in spinal lesions of 8-week-old control and Tcf7l2ΔHMG mice at 14 dpl; n=3 animals for each genotype. (l) Quantification of g-ratio of newly myelinated axons in spinal lesions of 8-week-old control and Tcf7l2ΔHMG mice at 14 dpl; n=3 animals for each genotype. P<0.001, Student's t-test. Data are presented as mean±s.e.m. **P<0.01, ***P<0.001; Student's t-test. Scale bars, 100 μm (a,b), 2 μm (c,j) and 50 μm (f,g).CC BY · PubMed Central
Figure 3 Transcriptome analysis of Tcf7l2-regulated genes and direct targets identified by ChIP-seq. (a) A representative scatter plot of RNA-seq (log2 scale) from control and Tcf7l2ΔHMG optic nerves at P12 (fold change>1.5). Downregulated genes are labelled in red colour and upregulated genes in blue colour. (b) Heatmap of representative altered gene expression in RNA-seq analysis of control and Tcf7l2ΔHMG optic nerves at P12. (c) GO analysis identified biological processes that involve genes significantly downregulated in Tcf7l2ΔHMG compared with control mice at P12. (d) qRT–PCR validation of downregulation of myelination-associated genes in Tcf7l2ΔHMG optic nerves compared with controls (n=three animals per genotype). (e) qRT–PCR analysis of expression of myelination-related genes in rat OPCs after transfection with control and the Tcf7l2-overexpressing (OE) vectors for 72 h; n=3 independent experiments. (f) Real-time qRT–PCR analysis of Tcf7l2 and Mbp expression in OL lineage cells. OPCs were cultured under differentiation conditions in medium containing T3 for 0, 1, 3 and 5 days (n=3 independent treatments). (g) Immunostaining for Tcf7l2 expression in OPCs (PDGFRα+), differentiating and maturating OLs (CNP+), terminal differentiated OL (MBP+) induced by triiodothyronine (T3) treatment of OPCs for 0, 1, 3 and 5 days (d), respectively. (h) Heatmap of Tcf7l2-binding signals in OPCs (left), iOLs (OPC exposure to T3 for 1day, middle) and mOLs (OPC exposure to T3 for 3 days, right). Each line on the y axis represents a genomic region ±1.0 kb flanking Tcf7l2 summits. (i) The Venn diagram demonstrates minimal overlap of Tcf7l2 occupancy between iOLs or mOLs and H4IIE liver cells. ChIP-seq binding profiles of Tcf7l2 around H3K27Ac peak summits in iOLs (j) and mOLs (k). (l) The distribution pattern of Tcf7l2-binding regions in mOLs mapped to their closest TSS sites. Data are presented as mean±s.e.m. *P<0.05, **P<0.01 and ***P<0.001; Student's t-test. Scale bar, 50 μm (g).
Figure 3 Transcriptome analysis of Tcf7l2-regulated genes and direct targets identified by ChIP-seq. (a) A representative scatter plot of RNA-seq (log2 scale) from control and Tcf7l2ΔHMG optic nerves at P12 (fold change>1.5). Downregulated genes are labelled in red colour and upregulated genes in blue colour. (b) Heatmap of representative altered gene expression in RNA-seq analysis of control and Tcf7l2ΔHMG optic nerves at P12. (c) GO analysis identified biological processes that involve genes significantly downregulated in Tcf7l2ΔHMG compared with control mice at P12. (d) qRT–PCR validation of downregulation of myelination-associated genes in Tcf7l2ΔHMG optic nerves compared with controls (n=three animals per genotype). (e) qRT–PCR analysis of expression of myelination-related genes in rat OPCs after transfection with control and the Tcf7l2-overexpressing (OE) vectors for 72 h; n=3 independent experiments. (f) Real-time qRT–PCR analysis of Tcf7l2 and Mbp expression in OL lineage cells. OPCs were cultured under differentiation conditions in medium containing T3 for 0, 1, 3 and 5 days (n=3 independent treatments). (g) Immunostaining for Tcf7l2 expression in OPCs (PDGFRα+), differentiating and maturating OLs (CNP+), terminal differentiated OL (MBP+) induced by triiodothyronine (T3) treatment of OPCs for 0, 1, 3 and 5 days (d), respectively. (h) Heatmap of Tcf7l2-binding signals in OPCs (left), iOLs (OPC exposure to T3 for 1day, middle) and mOLs (OPC exposure to T3 for 3 days, right). Each line on the y axis represents a genomic region ±1.0 kb flanking Tcf7l2 summits. (i) The Venn diagram demonstrates minimal overlap of Tcf7l2 occupancy between iOLs or mOLs and H4IIE liver cells. ChIP-seq binding profiles of Tcf7l2 around H3K27Ac peak summits in iOLs (j) and mOLs (k). (l) The distribution pattern of Tcf7l2-binding regions in mOLs mapped to their closest TSS sites. Data are presented as mean±s.e.m. *P<0.05, **P<0.01 and ***P<0.001; Student's t-test. Scale bar, 50 μm (g).CC BY · PubMed Central
Figure 4 Tcf7l2 coordinates with Kaiso to inhibit Wnt/β-catenin signalling during OL differentiation. (a) Kaiso and Tcf7l2/Tcf4 consensus sites are most overrepresented in Tcf7l2-binding regions of iOLs. (b) qRT–PCR analysis of Kaiso in OPCs under T3-containing differentiation conditions for indicated days; n=3 independent experiments. (c) Kaiso and CNP expression at indicated days after T3 treatment of rat OPCs. (d) Co-expression of Kaiso with Tcf7l2, PDGFRα, CNP and MBP at indicated days after T3 treatment of OPCs. Arrows indicate co-labelled cells. (e) Biological processes overrepresented in Tcf7l2-occupied regions in iOLs. (f) Tcf7l2-binding profiles in OPCs, iOLs and mOLs on representative Wnt-signalling gene loci. (g) Kaiso occupancy on Tcf7l2-binding sites in iOLs by ChIP–qPCR. Control: genomic segment lacking Tcf7l2-binding sites. (h) Topflash luciferase activity in Hek293T cells transfected with expression vectors for Kaiso, β-catenin or both together. (i) Kaiso co-immunoprecipitated with Tcf7l2 in iOLs. (j) Co-immunoprecipitation with anti-Tcf7l2 from Hek293T cells transfected with Tcf7l2 with β-catenin and Kaiso for 48 h. Glyceraldehydes 3-phosphate dehydrogenase (GAPDH) as a loading control. (k) qRT–PCR analysis of myelination-related genes in OPCs transfected with control or Kaiso-expressing vectors for 48 h; n=3 independent experiments. (l) Tcf7l2 occupancy by ChIP–PCR in rat OPCs transfected with control or Kaiso-expressing vectors on the promoters of targeted genes; n=3 independent experiments. (m) qRT–PCR analysis of myelination-related and Wnt signalling genes in OPCs transfected with scrambled control and Kaiso siRNAs; n=3 independent experiments. Expression of Kaiso and Tcf7l2 (n), as well as myelination-related genes (o) in Oli-neu cells transfected with control and Kaiso-overexpressing vectors and/or scrambled control and Tcf7l2-siRNAs; n=3 independent experiments. (p,q) The corpus callosum (arrows) of control and Kaiso−/− mutants at P7 were immunostained with CC1 and MBP (p). Panel q depicts the percentage of PDGFRα+ and CC1+ cells in the corpus callosum at P7; n=3 animals per genotype. Data are presented as mean±s.e.m. *P<0.05, **P<0.01 and ***P<0.001; Student's t-test, except in o with analysis of variance (ANOVA) and Newman–Keuls multiple comparison test. Scale bars, 50 μm (d) and 100 μm (p,q).
Figure 4 Tcf7l2 coordinates with Kaiso to inhibit Wnt/β-catenin signalling during OL differentiation. (a) Kaiso and Tcf7l2/Tcf4 consensus sites are most overrepresented in Tcf7l2-binding regions of iOLs. (b) qRT–PCR analysis of Kaiso in OPCs under T3-containing differentiation conditions for indicated days; n=3 independent experiments. (c) Kaiso and CNP expression at indicated days after T3 treatment of rat OPCs. (d) Co-expression of Kaiso with Tcf7l2, PDGFRα, CNP and MBP at indicated days after T3 treatment of OPCs. Arrows indicate co-labelled cells. (e) Biological processes overrepresented in Tcf7l2-occupied regions in iOLs. (f) Tcf7l2-binding profiles in OPCs, iOLs and mOLs on representative Wnt-signalling gene loci. (g) Kaiso occupancy on Tcf7l2-binding sites in iOLs by ChIP–qPCR. Control: genomic segment lacking Tcf7l2-binding sites. (h) Topflash luciferase activity in Hek293T cells transfected with expression vectors for Kaiso, β-catenin or both together. (i) Kaiso co-immunoprecipitated with Tcf7l2 in iOLs. (j) Co-immunoprecipitation with anti-Tcf7l2 from Hek293T cells transfected with Tcf7l2 with β-catenin and Kaiso for 48 h. Glyceraldehydes 3-phosphate dehydrogenase (GAPDH) as a loading control. (k) qRT–PCR analysis of myelination-related genes in OPCs transfected with control or Kaiso-expressing vectors for 48 h; n=3 independent experiments. (l) Tcf7l2 occupancy by ChIP–PCR in rat OPCs transfected with control or Kaiso-expressing vectors on the promoters of targeted genes; n=3 independent experiments. (m) qRT–PCR analysis of myelination-related and Wnt signalling genes in OPCs transfected with scrambled control and Kaiso siRNAs; n=3 independent experiments. Expression of Kaiso and Tcf7l2 (n), as well as myelination-related genes (o) in Oli-neu cells transfected with control and Kaiso-overexpressing vectors and/or scrambled control and Tcf7l2-siRNAs; n=3 independent experiments. (p,q) The corpus callosum (arrows) of control and Kaiso−/− mutants at P7 were immunostained with CC1 and MBP (p). Panel q depicts the percentage of PDGFRα+ and CC1+ cells in the corpus callosum at P7; n=3 animals per genotype. Data are presented as mean±s.e.m. *P<0.05, **P<0.01 and ***P<0.001; Student's t-test, except in o with analysis of variance (ANOVA) and Newman–Keuls multiple comparison test. Scale bars, 50 μm (d) and 100 μm (p,q).CC BY · PubMed Central
Figure 5 Tcf7l2 coordinates with Sox10 to regulate OL terminal differentiation. (a) De novo motif analysis identified Tcf7l2/Tcf4, Sox10-binding motifs as most significant binding motifs in Tcf7l2-binding regions in mOLs. (b) ChIP-seq binding profiles of Sox10 around Tcf7l2 peak summits in mOLs. (c) Heatmap of the signal intensities from ChIP-seq assays of Tcf7l2 and Sox10 across Tcf7l2-binding sites (±1 kb) called in mOLs. (d) Sox10 co-immunoprecipitated with Tcf7l2 in mOLs. (e) Visualization of Tcf7l2-binding profiles in OPCs, iOLs and mOLs on representative myelin gene loci (Mbp, Myrf, Olig1,Ugt8 and Zfp191). Sox10/Tcf7l2 co-occupancy (highlighted) in mOLs was also shown. (f) qRT–PCR assay for Mbp, Cnp expression in OPCs transfected with expression vectors for Tcf7l2, Sox10 or both; n=3 independent experiments. (g) The expression vector carrying Flag-Tcf7l2 was co-transfected with HA-Sox10 and a varied amount of Myc-Kaiso in 293T cells for 48 h. Lysates were co-immunoprecipitated with anti-Flag-Tcf7l2 and subjected to western blot analysis. Glyceraldehy 3-phosphate dehydrogense (GAPDH) as a loading control. (h) Model of Tcf7l2 regulation of OL differentiation through sequential interactions with Kaiso and Sox10 to promote stepwise OL lineage differentiation. At the onset of OPC differentiation, Tcf7l2 binds Kaiso to inhibit Wnt signalling activation and subsequently associates with Sox10 to promote OL maturation. Data are presented as mean±s.e.m. *P<0.05, **P<0.01 and ***P<0.001; analysis of variance (ANOVA) with Newman–Keuls multiple comparison test.
Figure 5 Tcf7l2 coordinates with Sox10 to regulate OL terminal differentiation. (a) De novo motif analysis identified Tcf7l2/Tcf4, Sox10-binding motifs as most significant binding motifs in Tcf7l2-binding regions in mOLs. (b) ChIP-seq binding profiles of Sox10 around Tcf7l2 peak summits in mOLs. (c) Heatmap of the signal intensities from ChIP-seq assays of Tcf7l2 and Sox10 across Tcf7l2-binding sites (±1 kb) called in mOLs. (d) Sox10 co-immunoprecipitated with Tcf7l2 in mOLs. (e) Visualization of Tcf7l2-binding profiles in OPCs, iOLs and mOLs on representative myelin gene loci (Mbp, Myrf, Olig1,Ugt8 and Zfp191). Sox10/Tcf7l2 co-occupancy (highlighted) in mOLs was also shown. (f) qRT–PCR assay for Mbp, Cnp expression in OPCs transfected with expression vectors for Tcf7l2, Sox10 or both; n=3 independent experiments. (g) The expression vector carrying Flag-Tcf7l2 was co-transfected with HA-Sox10 and a varied amount of Myc-Kaiso in 293T cells for 48 h. Lysates were co-immunoprecipitated with anti-Flag-Tcf7l2 and subjected to western blot analysis. Glyceraldehy 3-phosphate dehydrogense (GAPDH) as a loading control. (h) Model of Tcf7l2 regulation of OL differentiation through sequential interactions with Kaiso and Sox10 to promote stepwise OL lineage differentiation. At the onset of OPC differentiation, Tcf7l2 binds Kaiso to inhibit Wnt signalling activation and subsequently associates with Sox10 to promote OL maturation. Data are presented as mean±s.e.m. *P<0.05, **P<0.01 and ***P<0.001; analysis of variance (ANOVA) with Newman–Keuls multiple comparison test.CC BY · PubMed Central
Figure 6 Tcf7l2 regulates the expression of cholesterol biosynthetic genes in OLs. (a) Venn diagram shows the overlap between Tcf7l2-targeting genes and substantially altered genes detected by RNA-seq in Tcf7l2ΔHMG optic nerves (fold change>1.5 between Ctrl and mutant). (b) GO analysis of pathways overrepresented by direct Tcf7l2 target genes in mOLs. (c) Schematic view of de novo cholesterol biosynthetic pathway; the putative direct Tcf7l2 target genes are highlighted in red. (d) Genome browser view of the distribution of Tcf7l2, Sox10, Olig2, H3K27ac and H3K4me3 binding to promoter regions of cholesterol biosynthesis genes (Fdps, Fdft1, Lss, Cyp51, Hsd17b7 and Dhcr24) in OPCs, iOLs and mOLs as indicated. (e) ChIP–PCR assay for the enrichment of Tcf7l2 and Sox10 binding on the promoters of cholesterol biosynthesis genes over IgG controls; n=3 independent assays. (f) qRT–PCR analysis of the expression of cholesterol biosynthetic genes in Tcf7l2ΔHMG optic nerves versus controls; n=three animals per genotype. (g) Luciferase reporter activity driven by Tcf7l2-binding promoter/enhancer regions was assessed in 293T cells co-transfected with control and pcDNA3 expression vectors for Tcf7l2 or ΔHMG mutant Tcf7l2, or Srebf2; n=3 independent experiments. (h) qRT–PCR assay for the expression of cholesterol biosynthetic genes in OPCs transfected with the pcDNA3 expression vectors for control and Tcf7l2; n=3 independent experiments. Data are presented as mean±s.e.m. *P<0.05, **P<0.01 and ***P<0.001; Student's t-test, except in g with analysis of variance (ANOVA) and Newman–Keuls multiple comparison test.
Figure 6 Tcf7l2 regulates the expression of cholesterol biosynthetic genes in OLs. (a) Venn diagram shows the overlap between Tcf7l2-targeting genes and substantially altered genes detected by RNA-seq in Tcf7l2ΔHMG optic nerves (fold change>1.5 between Ctrl and mutant). (b) GO analysis of pathways overrepresented by direct Tcf7l2 target genes in mOLs. (c) Schematic view of de novo cholesterol biosynthetic pathway; the putative direct Tcf7l2 target genes are highlighted in red. (d) Genome browser view of the distribution of Tcf7l2, Sox10, Olig2, H3K27ac and H3K4me3 binding to promoter regions of cholesterol biosynthesis genes (Fdps, Fdft1, Lss, Cyp51, Hsd17b7 and Dhcr24) in OPCs, iOLs and mOLs as indicated. (e) ChIP–PCR assay for the enrichment of Tcf7l2 and Sox10 binding on the promoters of cholesterol biosynthesis genes over IgG controls; n=3 independent assays. (f) qRT–PCR analysis of the expression of cholesterol biosynthetic genes in Tcf7l2ΔHMG optic nerves versus controls; n=three animals per genotype. (g) Luciferase reporter activity driven by Tcf7l2-binding promoter/enhancer regions was assessed in 293T cells co-transfected with control and pcDNA3 expression vectors for Tcf7l2 or ΔHMG mutant Tcf7l2, or Srebf2; n=3 independent experiments. (h) qRT–PCR assay for the expression of cholesterol biosynthetic genes in OPCs transfected with the pcDNA3 expression vectors for control and Tcf7l2; n=3 independent experiments. Data are presented as mean±s.e.m. *P<0.05, **P<0.01 and ***P<0.001; Student's t-test, except in g with analysis of variance (ANOVA) and Newman–Keuls multiple comparison test.CC BY · PubMed Central
Figure 7 Induction of cholesterol biosynthetic pathway by Tcf7l2 is required for OL differentiation. (a) Inhibition of cholesterol biosynthetic genes in OPCs transfected with scrambled control siRNAs or siRNAs against Lss, Cyp51, Hsd17b7 and Dhcr24. (b) Downregulation of expression of myelin genes in OLs transfected with Cyp51, Lss, Dhcr24 and Hsd17b7 siRNAs; n=3 independent experiments. (c) OPCs isolated from control and Tcf7l2ΔHMG animals were treated with vehicle (Veh) and cholesterol (Chol) in culture for 4 days in OPC growth medium without PDGF-AA. Expression of CNP (green), MBP (red) and Olig2 (blue) were examined by immunostaining. Quantification of the percentage of CNP+ (d) and MBP+ (e) OL cells among Olig2+ cells in control and Tcf7l2ΔHMG cells treated with vehicle or cholesterol; n=three independent experiments. (f) qRT–PCR assay for the expression of myelin-associated genes in control and Tcf7l2ΔHMG OPCs treated with vehicle or cholesterol (Chol) for 4 days; n=3 independent experiments. (g,h) Pregnant female mice were fed with normal diet (ND) or 2% cholesterol diets at the time of gestation. The spinal cords of control and Tcf7l2ΔHMG pups were harvested at P14 and immunostained with CC1 (green) and MBP (red). Representative images were shown in g. Scale bar, 100 μm. The number of CC1+ OLs per area (1 mm2) were quantified in the spinal cord of control and Tcf7l2ΔHMG mutants (h); n=3 independent animals. Data are presented as mean±s.e.m. *P<0.05, **P<0.01 and ***P<0.001; Student's t-test in a. Analysis of variance (ANOVA) with Newman–Keuls multiple comparison test in d–f and h. Scale bar, 50 μm (c).
Figure 7 Induction of cholesterol biosynthetic pathway by Tcf7l2 is required for OL differentiation. (a) Inhibition of cholesterol biosynthetic genes in OPCs transfected with scrambled control siRNAs or siRNAs against Lss, Cyp51, Hsd17b7 and Dhcr24. (b) Downregulation of expression of myelin genes in OLs transfected with Cyp51, Lss, Dhcr24 and Hsd17b7 siRNAs; n=3 independent experiments. (c) OPCs isolated from control and Tcf7l2ΔHMG animals were treated with vehicle (Veh) and cholesterol (Chol) in culture for 4 days in OPC growth medium without PDGF-AA. Expression of CNP (green), MBP (red) and Olig2 (blue) were examined by immunostaining. Quantification of the percentage of CNP+ (d) and MBP+ (e) OL cells among Olig2+ cells in control and Tcf7l2ΔHMG cells treated with vehicle or cholesterol; n=three independent experiments. (f) qRT–PCR assay for the expression of myelin-associated genes in control and Tcf7l2ΔHMG OPCs treated with vehicle or cholesterol (Chol) for 4 days; n=3 independent experiments. (g,h) Pregnant female mice were fed with normal diet (ND) or 2% cholesterol diets at the time of gestation. The spinal cords of control and Tcf7l2ΔHMG pups were harvested at P14 and immunostained with CC1 (green) and MBP (red). Representative images were shown in g. Scale bar, 100 μm. The number of CC1+ OLs per area (1 mm2) were quantified in the spinal cord of control and Tcf7l2ΔHMG mutants (h); n=3 independent animals. Data are presented as mean±s.e.m. *P<0.05, **P<0.01 and ***P<0.001; Student's t-test in a. Analysis of variance (ANOVA) with Newman–Keuls multiple comparison test in d–f and h. Scale bar, 50 μm (c).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 66 references

Cited by

Items 101–173 of 173

Metadata

Authors
Zhao, C., Deng, Y., Liu, L., Yu, K., Zhang, L., Wang, H., He, X., Wang, J., Lu, C., Wu, L. N., Weng, Q., Mao, M., Li, J., van Es, J. H., Xin, M., Parry, L., Goldman, S. A., Clevers, H., & Lu, Q. R.
Affiliations
  • Cincinnati Children's Hospital Medical Center (US)
  • Sichuan University (CN)
  • Zhejiang University (CN)
  • Texas A&M University (US)
  • Cardiff University (GB)
  • University of Rochester Medicine (US)
  • Hubrecht Institute for Developmental Biology and Stem Cell Research (NL)
Corresponding author
Lu, Q. Richard
Venue
Nature Communications
Published
2016-03-09
Volume
7
Issue
1
Pages
10883-10883
ISSN
2041-1723 (ISSN-L)
OpenAlex
W2294920993
Cited by
154
References
66
Citations by year
2026: 6 · 2025: 12 · 2024: 15 · 2023: 15 · 2022: 22 · 2021: 19 · 2020: 15 · 2019: 14 · 2018: 10 · 2017: 17 · 2016: 9
FWCI
8.51
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • KNAW Research Portal (The Royal Netherlands Academy of Arts and Sciences) (publishedVersion, other-oa)
  • KNAW research portal (Royal Academy of Art and Sciences (KNAW)) (publishedVersion, other-oa)
  • ORCA Online Research @Cardiff (Cardiff University) (acceptedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
  • OakTrust (Texas A&M University Libraries) (submittedVersion)
Funders
  • National Multiple Sclerosis Society (RG3978)
  • Multiple Sclerosis Society
  • Novo Nordisk Fonden (NNF13OC0004260)
  • National Institutes of Health (UL1TR001425)
  • National Institute of Mental Health (R01MH104701, R01MH099578)
  • National Institute of Neurological Disorders and Stroke (R01NS075243, R01NS072427, R01NS075345, R37NS096359)
  • National Center for Advancing Translational Sciences
Topics
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
Keywords
TCF7L2, TCF4, oligodendrocyte differentiation, myelination, Wnt/β-catenin signaling, SOX10, transcriptional coregulators, cholesterol biosynthesis, CNS myelination
MeSH terms
Animals, Gene Expression Regulation, Mice, Inbred C57BL, Nervous System, Oligodendroglia, Protein Binding, Species Specificity, Transcription Factors, Signal Transduction, Mice, Knockout, Gene Expression Regulation, Developmental, Mice, SOXE Transcription Factors, Transcription Factor 7-Like 2 Protein

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.